CCCC — C4 Therapeutics Inc · rev $12.8M

C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.

Latest reported CCCC revenue for 2026-06-30 was $12.8M. Net income was -$48.8M. CCCC currently screens at market cap $425.7M.

Use this CCCC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CCCC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CCCC SEC filings page. Lician reads the product cache first so this HTML stays unique to C4 Therapeutics Inc even when a live quote feed is slow.

C4 Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full CCCC income, balance, and cash tables.

  • Revenue$35.9M
  • Net Income-$105.0M
  • Total Assets$359.1M
  • Total Debt$0
  • Free Cash Flow-$99.3M

CCCC recent filings